Mannkind (MNKD) Cash & Equivalents Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 67.78% |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 11.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.51% |
| Dec 31, 2025 | 59.07% |
| Sep 30, 2025 | 101.86% |
| Jun 30, 2025 | -41.46% |
| Mar 31, 2025 | -75.14% |
| Dec 31, 2024 | -80.26% |
| Sep 30, 2024 | -23.98% |
| Jun 30, 2024 | 12.99% |
| Mar 31, 2024 | 125.08% |
| Dec 31, 2023 | 241.82% |
| Sep 30, 2023 | 52.86% |
| Jun 30, 2023 | 142.77% |
| Mar 31, 2023 | 27.78% |
| Dec 31, 2022 | -43.82% |
| Sep 30, 2022 | 5.04% |
| Jun 30, 2022 | -43.20% |
| Mar 31, 2022 | -72.88% |
| Dec 31, 2021 | 85.34% |
| Sep 30, 2021 | -1.33% |
| Jun 30, 2021 | -1.14% |
| Mar 31, 2021 | 537.63% |
| Dec 31, 2020 | 124.05% |
| Sep 30, 2020 | 73.66% |
| Jun 30, 2020 | 693.45% |
| Mar 31, 2020 | 12.56% |
| Dec 31, 2019 | -57.97% |
| Sep 30, 2019 | 188.85% |
| Jun 30, 2019 | -69.56% |
| Mar 31, 2019 | 29.30% |
| Dec 31, 2018 | 61.92% |
| Sep 30, 2018 | 4.46% |
| Jun 30, 2018 | -39.66% |
| Mar 31, 2018 | -44.34% |
| Dec 31, 2017 | 91.95% |
| Sep 30, 2017 | -71.85% |
| Jun 30, 2017 | -31.93% |
| Mar 31, 2017 | 73.50% |
| Dec 31, 2016 | -61.24% |
| Sep 30, 2016 | 7.90% |
| Jun 30, 2016 | -40.54% |
| Mar 31, 2016 | -77.12% |
| Dec 31, 2015 | -51.11% |
| Sep 30, 2015 | -80.91% |
| Jun 30, 2015 | 160.07% |
| Mar 31, 2015 | 237.94% |
| Dec 31, 2014 | 70.70% |
| Sep 30, 2014 | 83.86% |
| Jun 30, 2014 | 44.46% |
| Mar 31, 2014 | 27.69% |
| Dec 31, 2013 | 14.47% |
| Sep 30, 2013 | 5,214.62% |
| Jun 30, 2013 | -9.83% |
| Mar 31, 2013 | -50.31% |
| Dec 31, 2012 | 2,206.60% |
| Sep 30, 2012 | -92.25% |
| Jun 30, 2012 | 27.73% |
| Mar 31, 2012 | 20.13% |
| Dec 31, 2011 | -95.94% |
| Sep 30, 2011 | -76.73% |
| Jun 30, 2011 | -12.65% |